Abcam, ab279721, Anti-Adropin antibody [EPR24382-57] - BSA and Azide free

Size: 100µg / 1mg
Rabbit Recombinant Monoclonal Adropin antibody. Carrier free. Suitable for IP, WB and reacts with Rat, Mouse, Human samples.
Key facts
Host species:Rabbit,
Clonality:Monoclonal,
Clone number:EPR24382-57,
Isotype:IgG,
Carrier free:Yes,
Reacts with:Mouse, Rat, Human,
Applications:IP, WBSee reactivity dataSee the reactivity data table below for information on validated species and application combinations.,
Immunogen:The exact immunogen used to generate this antibody is proprietary information.

Product details:
ab279721 is the carrier-free version of
ab279716
Patented technology
Our RabMAb
technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to
RabMAb® patents
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- High batch-to-batch consistency and reproducibility
- Improved sensitivity and specificity
- Long-term security of supply
- Animal-free batch production
For more information, read more on
recombinant antibodies
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our
conjugation kits
for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar
Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar
is a trademark of Fluidigm Canada Inc.

Properties and Storage Information:
Form-Liquid, Purification technique-Affinity purification Protein A, Storage buffer-Constituents: PBS, Shipped at conditions-Blue Ice, Appropriate short-term storage conditions-+4°C, Appropriate long-term storage conditions-+4°C

Supplementary Information:
This supplementary information is collated from multiple sources and compiled automatically.
Adropin is a secreted peptide hormone also known as Energy Homeostasis Associated (ENHO) gene product. This protein has a mass of approximately 4.5 kDa and is primarily expressed in the liver and brain but also in the pancreas and various peripheral tissues. Adropin plays a role in regulating metabolic homeostasis influencing lipid metabolism and glucose levels through its action. It facilitates communication within cells to maintain energy balance and research shows its involvement in modulating insulin sensitivity.
Biological function summary
Adropin influences glucose homeostasis and fatty acid metabolism. It does not form part of a larger complex but functions as a solitary signaling molecule. The protein impacts cellular processes by increasing glucose oxidation and reducing fatty acid oxidation contributing to energy balance. Studies have demonstrated its role in influencing cardiovascular functions and central nervous systems processes which link it to various metabolic conditions.
Pathways
Adropin is involved in the regulation of energy balance through the insulin signaling pathway and the AMPK pathway. Both pathways help manage glucose uptake and energy expenditure. In the insulin signaling pathway adropin works alongside other proteins like PPARγ and GLUT4 to control glucose levels. Adropin's role in the AMPK pathway relates to cellular energy charge and helps maintain metabolic health by modulating lipid and glucose metabolism.
Adropin has potential links to obesity and type 2 diabetes where it might contribute to pathophysiologies. Its reduced levels are often observed in patients with these conditions. The association to disorders involves interaction with proteins such as insulin receptor substrate (IRS) and adiponectin which mediate metabolic responses affecting glucose and lipid homeostasis. Understanding adropin's actions in these contexts could assist in the development of novel therapeutic strategies targeting metabolic disorders.